{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:49:52Z","timestamp":1793087392939,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.ijrobp.2009.04.060","type":"journal-article","created":{"date-parts":[[2009,9,9]],"date-time":"2009-09-09T08:56:04Z","timestamp":1252486564000},"page":"9-15","source":"Crossref","is-referenced-by-count":24,"title":["Radiochemotherapy With Cetuximab, Cisplatin, and Amifostine for Locally Advanced Head and Neck Cancer: A Feasibility Study"],"prefix":"10.1016","volume":"77","author":[{"given":"Michael I.","family":"Koukourakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pelagia G.","family":"Tsoutsou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonios","family":"Karpouzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Tsiarkatsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilias","family":"Karapantzos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilios","family":"Daniilidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantinos","family":"Kouskoukis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2009.04.060_bib1","unstructured":"Forastiere AA, Ang KK, Brizel DNY. Head and neck cancers. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology, version 2.2008. http:\/\/www.nccn.org."},{"key":"10.1016\/j.ijrobp.2009.04.060_bib2","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1634\/theoncologist.2007-0157","article-title":"Multidisciplinary management of locally advanced SCCHN: Optimizing treatment outcomes","volume":"13","author":"Ang","year":"2008","journal-title":"Oncologist"},{"key":"10.1016\/j.ijrobp.2009.04.060_bib3","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(00)90011-4","article-title":"Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data","volume":"355","author":"Pignon","year":"2000","journal-title":"Lancet"},{"issue":"Suppl","key":"10.1016\/j.ijrobp.2009.04.060_bib4","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1200\/jco.2004.22.14_suppl.5505","article-title":"Update of MACH-NC (meta-analysis of chemotherapy in head and neck cancer) database focused on concomitant chemoradiotherapy","volume":"22","author":"Bourhis","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2009.04.060_bib5","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0140-6736(06)69121-6","article-title":"for the Meta-Analysis of Radiotherapy in Carcinomas of Head and Neck (MARCH) Collaborative Group. Hyperfractionated or accelerated radiotherapy in head and neck cancer: A meta-analysis","volume":"368","author":"Bourhis","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2009.04.060_bib6","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0140-6736(03)14361-9","article-title":"Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial","volume":"362","author":"Overgaard","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2009.04.060_bib7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0360-3016(00)00663-5","article-title":"A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003","volume":"48","author":"Fu","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.04.060_bib8","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1200\/JCO.2006.08.057","article-title":"Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: A GORTEC trial","volume":"24","author":"Bourhis","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2009.04.060_bib9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0167-8140(92)90242-M","article-title":"Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: Final analysis of a randomized trial of the EORTC cooperative group of radiotherapy","volume":"25","author":"Horiot","year":"1992","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2009.04.060_bib10","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1056\/NEJM199806183382503","article-title":"Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer","volume":"338","author":"Brizel","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2009.04.060_bib11","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2009.04.060_bib12","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJMoa0802656","article-title":"Platinum-based chemotherapy plus cetuximab in head and neck cancer","volume":"359","author":"Vermorken","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ijrobp.2009.04.060_bib13","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1200\/JCO.2000.18.19.3339","article-title":"Phase III randomized trial of amifostine as a radioprotector in head and neck cancer","volume":"18","author":"Brizel","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2009.04.060_bib14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/09553000701616114","article-title":"Hypoxia inducible factor (HIF1alpha and HIF2alpha) and carbonic anhydrase 9 (CA9) expression and response of head-neck cancer to hypofractionated and accelerated radiotherapy","volume":"84","author":"Koukourakis","year":"2008","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.ijrobp.2009.04.060_bib15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0167-8140(91)90033-D","article-title":"Dose fractionation and tumour repopulation in radiotherapy for bladder cancer","volume":"21","author":"Maciejewski","year":"1991","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2009.04.060_bib16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0360-3016(95)02102-7","article-title":"The impact of overall treatment time on the results of radiotherapy for nonsmall cell lung carcinoma","volume":"34","author":"Koukourakis","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.04.060_bib17","first-page":"2437","article-title":"Individualization of the subcutaneous amifostine dose during hypofractionated\/accelerated radiotherapy","volume":"26","author":"Koukourakis","year":"2006","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijrobp.2009.04.060_bib18","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ijrobp.2004.02.026","article-title":"Assessment and management of cutaneous reactions with amifostine administration: Findings of the ethyol (amifostine) cutaneous treatment advisory panel (ECTAP)","volume":"60","author":"Boccia","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.04.060_bib19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/02841860510007396","article-title":"Overgaard J for the Danish Head and Neck Cancer study group (DAHANCA). The role of epidermal growth factor receptor and E-cadherin for the outcome of reduction in the overall treatment time of radiotherapy of supraglottic larynx squamous cell carcinoma","volume":"44","author":"Eriksen","year":"2005","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2009.04.060_bib20","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1200\/JCO.2005.02.7474","article-title":"Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial","volume":"24","author":"Koukourakis","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2009.04.060_bib21","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.radonc.2008.09.007","article-title":"High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: Results of a survey in EORTC institutes","volume":"90","author":"Giro","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2009.04.060_bib22","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.radonc.2008.09.018","article-title":"Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer","volume":"90","author":"Pryor","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2009.04.060_bib23","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2004.00.1792","article-title":"Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: A pilot phase II study of a new combined-modality paradigm","volume":"24","author":"Pfister","year":"2006","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301609006592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301609006592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T03:28:04Z","timestamp":1545017284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301609006592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0360301609006592"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2009.04.060","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1168170.630309","asserted-by":"object"}]},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}